Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1468679/000101905621000307/acryo_2q21.htm
SEC Filings
CRYO Annual Reports
10-K Annual Report January 2022
10-K Annual Report January 2021
10-K Annual Report January 2020
10-K Annual Report January 2019
10-K Annual Report January 2018
10-K Annual Report January 2018
10-K Annual Report January 2017
10-K Annual Report January 2017
10-K Annual Report January 2016
10-K Annual Report January 2016
10-K Annual Report January 2022
10-K Annual Report January 2021
10-K Annual Report January 2020
10-K Annual Report January 2019
10-K Annual Report January 2018
10-K Annual Report January 2018
10-K Annual Report January 2017
10-K Annual Report January 2017
10-K Annual Report January 2016
10-K Annual Report January 2016
CRYO Quarterly Reports
CRYO Corporate News
Bylaw Change
Financial Exhibit November 2021
Financial Exhibit
Regulated Disclosure April 2018
Financial Exhibit
Regulated Disclosure April 2018
Accountant Change
Financial Exhibit December 2017
Accountant Change
Financial Exhibit December 2017
Accountant Change January 2017
Accountant Change January 2017
Accountant Change
Financial Exhibit June 2011
Accountant Change
Financial Exhibit June 2011
Bylaw Change
Financial Exhibit June 2011
Bylaw Change
Financial Exhibit
Financial Exhibit
November 2021
Financial Exhibit
Regulated Disclosure
Regulated Disclosure
April 2018
Financial Exhibit
Regulated Disclosure
Regulated Disclosure
April 2018
Accountant Change
Financial Exhibit
Financial Exhibit
December 2017
Accountant Change
Financial Exhibit
Financial Exhibit
December 2017
Accountant Change
January 2017
Accountant Change
January 2017
Accountant Change
Financial Exhibit
Financial Exhibit
June 2011
Accountant Change
Financial Exhibit
Financial Exhibit
June 2011
Bylaw Change
Financial Exhibit
Financial Exhibit
June 2011
Last10K.com | 10-Q Quarterly Report Mon May 17 2021
Document and Entity Information - shares | 6 Months Ended | |
|---|---|---|
Mar. 31, 2021 | May 15, 2021 | |
| Cover [Abstract] | ||
| Entity Registrant Name | AMERICAN CRYOSTEM Corp | |
| Document Type | 10-Q | |
| Document Period End Date | Mar. 31, 2021 | |
| Amendment Flag | false | |
| Entity Central Index Key | 0001468679 | |
| Current Fiscal Year End Date | --09-30 | |
| Entity Common Stock, Shares Outstanding | 60,833,131 | |
| Entity Filer Category | Non-accelerated Filer | |
| Entity Emerging Growth Company | false | |
| Entity Small Business | true | |
| Entity Current Reporting Status | Yes | |
| Entity Shell Company | false | |
| Entity Interactive Data Current | Yes | |
| Entity Incorporation, State or Country Code | NV | |
| Entity File Number | 000-54672 | |
| Document Fiscal Year Focus | 2021 | |
| Document Fiscal Period Focus | Q2 |
View differences made from one quarter to another to evaluate American Cryostem Corp's financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by American Cryostem Corp.
Assess how American Cryostem Corp's management team is paid from their Annual Proxy
American Cryostem Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statement Of Changes In Shareholder's Deficit
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
1. Organization Of The Company And Significant Accounting Policies
1. Organization Of The Company And Significant Accounting Policies (Details Narrative)
1. Organization Of The Company And Significant Accounting Policies (Details)
1. Organization Of The Company And Significant Accounting Policies (Policies)
1. Organization Of The Company And Significant Accounting Policies (Tables)
10. Fair Values Of Financial Instruments
11. Leases
11. Leases (Details 1)
11. Leases (Details 2)
11. Leases (Details 3)
11. Leases (Details Narrative)
11. Leases (Details)
11. Leases (Tables)
12. Concentrations Of Credit
12. Concentrations Of Credit (Details Narrative)
13. Investments
14. Related Party Transactions
14. Related Party Transactions (Details Narrative)
15. Subsequent Events
2. Going Concern
3. Revenue Recognition
3. Revenue Recognition (Details)
3. Revenue Recognition (Tables)
4. Loss Per Share
4. Loss Per Share (Details Narrative)
4. Loss Per Share (Details)
4. Loss Per Share (Tables)
5. Fixed Assets
5. Fixed Assets (Details Narrative)
5. Fixed Assets (Details)
5. Fixed Assets (Tables)
6. Patent &Amp; Patents Filings (Details Narrative)
6. Patent &Amp; Patents Filings (Details)
6. Patent &Amp; Patents Filings (Tables)
6. Patents &Amp; Patents Filings
7. Debt
7. Debt (Details)
7. Debt (Tables)
8. Common Stock Issuances
8. Common Stock Issuances (Details Narrative)
9. Option Issuances
9. Option Issuances (Details Narrative)
9. Option Issuances (Details)
9. Option Issuances (Tables)
Material Contracts, Statements, Certifications & more
American Cryostem Corp provided additional information to their SEC Filing as exhibits
Ticker: CRYO
CIK: 1468679
Form Type: 10-Q Quarterly Report
Accession Number: 0001019056-21-000307
Submitted to the SEC: Mon May 17 2021 4:30:47 PM EST
Accepted by the SEC: Mon May 17 2021
Period: Wednesday, March 31, 2021
Industry: Health And Allied
External Resources:
Stock Quote
Social Media
SEC.gov
Bookmark the Permalink: https://last10k.com/sec-filings/cryo/0001019056-21-000307.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...